We, therefore, set out to evaluate whether miR-34a may target the WNT1/β-catenin pathway and, subsequently, induce an E-P cadherin switch during cervical cancer development regulated by HPV-16 E6/E7. This evidence concerns the gene WNT1 and cervical cancer.